These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 27053302)

  • 21. Neuroprotective Effects of Probucol against Rotenone-Induced Toxicity via Suppression of Reactive Oxygen Species Production in SH-SY5Y Cells.
    Takeo T; Miyake M; Mizuno H
    Biol Pharm Bull; 2024; 47(6):1154-1162. PubMed ID: 38880623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lithium protects dopaminergic cells from rotenone toxicity via autophagy enhancement.
    Hou L; Xiong N; Liu L; Huang J; Han C; Zhang G; Li J; Xu X; Lin Z; Wang T
    BMC Neurosci; 2015 Nov; 16():82. PubMed ID: 26608648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroprotective effect of curcumin as evinced by abrogation of rotenone-induced motor deficits, oxidative and mitochondrial dysfunctions in mouse model of Parkinson's disease.
    Khatri DK; Juvekar AR
    Pharmacol Biochem Behav; 2016; 150-151():39-47. PubMed ID: 27619637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble epoxide hydrolase inhibitor, APAU, protects dopaminergic neurons against rotenone induced neurotoxicity: Implications for Parkinson's disease.
    Lakkappa N; Krishnamurthy PT; M D P; Hammock BD; Hwang SH
    Neurotoxicology; 2019 Jan; 70():135-145. PubMed ID: 30472438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycitein exerts neuroprotective effects in Rotenone-triggered oxidative stress and apoptotic cell death in the cellular model of Parkinson's disease.
    Dong N; Yang Z
    Acta Biochim Pol; 2022 Jun; 69(2):447-452. PubMed ID: 35691030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sirt3 attenuates hydrogen peroxide-induced oxidative stress through the preservation of mitochondrial function in HT22 cells.
    Dai SH; Chen T; Wang YH; Zhu J; Luo P; Rao W; Yang YF; Fei Z; Jiang XF
    Int J Mol Med; 2014 Oct; 34(4):1159-68. PubMed ID: 25090966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of SIRT3 on mitochondrial functions and oxidative stress in Parkinson's disease.
    Shen Y; Wu Q; Shi J; Zhou S
    Biomed Pharmacother; 2020 Dec; 132():110928. PubMed ID: 33128944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ghrelin protects MES23.5 cells against rotenone via inhibiting mitochondrial dysfunction and apoptosis.
    Yu J; Xu H; Shen X; Jiang H
    Neuropeptides; 2016 Apr; 56():69-74. PubMed ID: 26459609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of γ-oryzanol in reducing neuromotor deficits, dopamine depletion and oxidative stress in a Drosophila melanogaster model of Parkinson's disease induced by rotenone.
    Araujo SM; de Paula MT; Poetini MR; Meichtry L; Bortolotto VC; Zarzecki MS; Jesse CR; Prigol M
    Neurotoxicology; 2015 Dec; 51():96-105. PubMed ID: 26366809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intersecting pathways to neurodegeneration in Parkinson's disease: effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin-proteasome system.
    Betarbet R; Canet-Aviles RM; Sherer TB; Mastroberardino PG; McLendon C; Kim JH; Lund S; Na HM; Taylor G; Bence NF; Kopito R; Seo BB; Yagi T; Yagi A; Klinefelter G; Cookson MR; Greenamyre JT
    Neurobiol Dis; 2006 May; 22(2):404-20. PubMed ID: 16439141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroprotective effect of CNB-001, a novel pyrazole derivative of curcumin on biochemical and apoptotic markers against rotenone-induced SK-N-SH cellular model of Parkinson's disease.
    Jayaraj RL; Tamilselvam K; Manivasagam T; Elangovan N
    J Mol Neurosci; 2013 Nov; 51(3):863-70. PubMed ID: 23900721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quercetin up-regulates mitochondrial complex-I activity to protect against programmed cell death in rotenone model of Parkinson's disease in rats.
    Karuppagounder SS; Madathil SK; Pandey M; Haobam R; Rajamma U; Mohanakumar KP
    Neuroscience; 2013 Apr; 236():136-48. PubMed ID: 23357119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. D-beta-hydroxybutyrate protects dopaminergic SH-SY5Y cells in a rotenone model of Parkinson's disease.
    Imamura K; Takeshima T; Kashiwaya Y; Nakaso K; Nakashima K
    J Neurosci Res; 2006 Nov; 84(6):1376-84. PubMed ID: 16917840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Small-molecule inhibitors at the PSD-95/nNOS interface attenuate MPP+-induced neuronal injury through Sirt3 mediated inhibition of mitochondrial dysfunction.
    Hu W; Guan LS; Dang XB; Ren PY; Zhang YL
    Neurochem Int; 2014 Dec; 79():57-64. PubMed ID: 25452082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resveratrol regulates mitochondrial reactive oxygen species homeostasis through Sirt3 signaling pathway in human vascular endothelial cells.
    Zhou X; Chen M; Zeng X; Yang J; Deng H; Yi L; Mi MT
    Cell Death Dis; 2014 Dec; 5(12):e1576. PubMed ID: 25522270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blockade of metabotropic glutamate receptor 5 protects against DNA damage in a rotenone-induced Parkinson's disease model.
    Xia N; Zhang Q; Wang ST; Gu L; Yang HM; Liu L; Bakshi R; Yang H; Zhang H
    Free Radic Biol Med; 2015 Dec; 89():567-80. PubMed ID: 26454081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroprotection of deferoxamine on rotenone-induced injury via accumulation of HIF-1 alpha and induction of autophagy in SH-SY5Y cells.
    Wu Y; Li X; Xie W; Jankovic J; Le W; Pan T
    Neurochem Int; 2010 Oct; 57(3):198-205. PubMed ID: 20546814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 5-Phenyl valeric acid attenuates α-synuclein aggregation and endoplasmic reticulum stress in rotenone-induced Parkinson's disease rats: A molecular mechanistic study.
    Kaur N; Singh R; Dhingra N; Kaur T
    Biochem Pharmacol; 2024 Aug; 226():116343. PubMed ID: 38852645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroprotective effect of the antiparkinsonian drug pramipexole against nigrostriatal dopaminergic degeneration in rotenone-treated mice.
    Inden M; Kitamura Y; Tamaki A; Yanagida T; Shibaike T; Yamamoto A; Takata K; Yasui H; Taira T; Ariga H; Taniguchi T
    Neurochem Int; 2009 Dec; 55(8):760-7. PubMed ID: 19647776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxidized nicotinamide adenine dinucleotide-dependent mitochondrial deacetylase sirtuin-3 as a potential therapeutic target of Parkinson's disease.
    Zhou ZD; Tan EK
    Ageing Res Rev; 2020 Sep; 62():101107. PubMed ID: 32535274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.